Lysosomal degradability of poly(α-amino acids)

Journal of Biomedical Materials Research

Volumn 34, Issue 3, 1997, Pages 381-392

  Chiu, Hsin Cheng ^a,c   Kopečková, Pavla ^a   Deshmane, Sharad S ^b   Kopeček, Jindřich ^a  

^a UNIVERSITY OF UTAH   (United States)

^b Sigma Chemical Company   (United States)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; COPOLYMERS; DRUG THERAPY; MACROMOLECULES; MASS SPECTROMETRY; ORGANIC ACIDS;

CHYMOTRYPSIN; DRUG CARRIERS; ELECTROSPRAY MASS SPECTROSCOPY; GLUTAMIC ACID; LYSOSOMAL DEGRADABILITY; LYSOSOMES; NITROANILINE; PAPAIN; POLYAMINO ACIDS; TRIPEPTIDYL NITROANILIDES;

POLYPEPTIDES;

ALPHA AMINO ACID; DRUG CARRIER; POLYPEPTIDE;

AMINO ACID ANALYSIS; ARTICLE; BIODEGRADATION; LYSOSOME; MASS SPECTROMETRY; POLYMERIZATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; LYSOSOMES; MASS SPECTROMETRY; MATERIALS TESTING; OLIGOPEPTIDES; PEPTIDES; POLYGLUTAMIC ACID; RATS;

EID: 0031553833     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19970305)34:3<381::AID-JBM13>3.0.CO;2-J     Document Type: Article

References (54)

1. J. M. Anderson, D. F. Gibbons, R. L. Martin, A. Hiltner, and R. Woods, "The potential for poly-α-amino acids as biomaterials," J. Biomed. Mater. Res. Symp., 5, 197-207 (1974).
2. D. Putnam and J. Kopeček, "Polymer conjugates with anticancer activity," Adv. Polym. Sci., 22, 55-123 (1995).
3. R. Duncan, "Lysosomal degradation of polymers used as drug carriers," CRC Crit. Rev. Biocompat., 2, 127-145 (1986).
4. J. Drobník, "Biodegradable soluble macromolecules as drug carriers," Adv. Drug. Deliv. Rev., 3, 229-245 (1989).
5. C. J. T. Hoes, J. Grootoonk, R. Duncan, I. C. Hume, M. Bhakoo, J. M. W. Bouma, and J. Feijen, "Biological properties of adriamycin bound to biodegradable polymeric carriers," J. Controlled Release, 23, 37-54 (1993).
6. Y. Kato, N. Umemoto, Y. Kayama, H. Fukushima, Y. Takeda, T. Hara, and Y. Ysukada, "A novel method of conjugation of daunomycin with antibody with a polyL-glutamic acid derivative as intermediate drug carrier. An anti-α-fetoprotein antibody-daunomycin conjugate," J. Med. Chem., 27, 1602-1607 (1984).
7. C. F. Roos, S. Matsumoto, Y. Takakura, M. Hashida, and H. Sezaki, "Physicochemical and antitumor characteristics of some polyamino acid prodrugs of mitomycin C," Int. J. Pharm., 22, 75-87 (1984).
8. D. Bayley, M.-R. Sancho, J. Brown, L. Brookman, K. Petrak, P. Goddard, and A. Steward, "Soluble polymeric carriers for drug delivery. 6: Preparation and biodistribution of N-hydroxyethyl-L-glutamine-co-L-glutamic acid copolymers in rats," J. Bioact. Compat. Polym., 8, 51-68 (1993).
9. M. Yokoyama, "Block copolymers as drug carriers," Crit. Rev. Therap. Drug Carrier Syst., 9, 213-248 (1992).
10. X. Li, D. B. Bennett, N. W. Adams, and S. W. Kim, "Poly(α-amino acid)-drug conjugates: a biodegradable injectable drug delivery system," in Polymeric Drugs and Drug Delivery Systems, R. L. Dunn and R. M. Ottenbrite (eds.), ACS, Washington, D.C., 1991, pp. 101-116.
11. J. A. Clegg, F. Hudecz, G. Mezo, M. V. Pimm, M. Szekerke, and R. W. Baldwin, "Carrier design: biodistribution of branched polypeptides with a poly(L-lysine) backbone," Bioconjugate Chem., 1, 425-430 (1990).
12. F. Zunino, G. Pratesi, and A. Micheloni, "Poly(carboxylic acid) polymers as carriers for anthracyclines," J. Controlled Release, 10, 65-73 (1989).
13. F. Rypáček, V. Saudek, J. Pytela, and V. Škarda, "Polyglutamines - versatile biodegradable carriers," Makromol. Chem., Suppl. 9, 129-135 (1985).
14. H. J.-P. Ryser and W.-C. Shen, "Drug-poly(lysine) conjugates: their potential for chemotherapy and for the study of endocytosis," in Targeting of Drugs with Synthetic Systems, G. Gregoriadis, J. Senior, and G. Poste (eds.), Plenum, New York, 1986, pp. 103-121.
15. L. A. McCormick-Thomson, D. Sgouras, and R. Duncan, "Poly(amino acid) copolymers as a potential soluble drug delivery system. 2. Body distribution and preliminary biocompatibility testing in vitro and in vivo," J. Bioact. Compat. Polym., 4, 252-268 (1989).
16. W.-C. Shen and H.J.-P. Ryser, "Poly(L-lysine) and poly(D-lysine) conjugates of methotrexate: different inhibitory effect on drug resistant cells," Mol. Pharmacol., 16, 614-622 (1979).
17. C. J. T. Hoes, W. Potman, W. A. R. van Heeswijk, J. Mud, B. G. de Grooth, J. Greve, and J. Feijen, "Optimization of macromolecular prodrugs of antitumor antibiotic adriamycin," J. Controlled Release, 2, 205-213 (1985).
18. C. J. T. Hoes, W. Potman, B. G. de Grooth, J. Greve, and J. Feijen, "Chemical control of drug delivery" in Innovative Approaches in Drug Research, A. F. Harms (ed.), Elsevier, Amsterdam, 1986, pp. 267-283.
19. N. L. Krinick and J. Kopeček, "Soluble polymers as targetable drug carriers," in Handbook of Experimental Pharmacology, Vol. 100 Targeted Drug Delivery, R. L. Juliano (ed.), Springer-Verlag, Berlin, 1991, pp. 105-179.
20. S. Foster and J. B. Lloyd, "Solute translocation across the mammalian lysosome membrane," Biochim. Biophys. Acta, 947, 465-491 (1988).
21. P. Goddard and K. Petrak, "Biodegradation of drug modified polymers in drug delivery - a critical analysis," J. Bioact. Compat. Polym., 4, 372-402 (1989).
22. G. D. Fasman, C. Lindblow, and E. Bodenheimer, "Conformational studies on synthetic poly-α-amino acids. Factors influencing the stability of the helical conformation of poly-L-glutamic acid and copolymers of L-glutamic acid and L-leucine," Biochemistry, 3, 155-166 (1964).
23. M. Sela and E. Katchalski, "Biological properties of poly-α-amino acids," Adv. Protein Chem., 14, 391-477 (1959).
24. E. E. Dellert and M. A. Stahmann, "Inhibition, restoration and enhancement of proteolytic action by polylysine and polyglutamic acid," Nature, 26, 1028-1029 (1955).
25. J. Kopeček, "The potential of water-soluble polymeric carriers in targeted and site-specific drug delivery," J. Controlled Release, 11, 279-290 (1990).
26. R. Duncan and J. Kopeček, "Soluble synthetic polymers as potential drug carriers," Adv. Polym. Sci., 57, 51-101 (1984).
27. J. Kopeček, "Controlled biodegradability of polymers - a key to drug delivery systems," Biomaterials, 5, 19-25 (1984).
28. P. Rejmanová, J. Kopeček, J. Pohl, M. Baudyš, and V. Kostka, "Polymers containing enzymatically degradable bonds. 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B," Makromol. Chem., 184, 2009-2020 (1983).
29. R. Duncan, H. C. Cable, J. B. Lloyd, P. Rejmanová, and J. Kopeček, "Polymers containing enzymatically degradable bonds. 7. Design of oligopeptide side-chains in poly[N-(2-hydroxypropyl)methacrylamide] copolymers to promote efficient degradation by lysosomal enzymes," Makromol. Chem., 184, 1997-2008 (1983).
30. L. A. McCormick-Thomson and R. Duncan, "Poly(amino acid) copolymers as a potential soluble drug delivery system. 1. Pinocytic uptake and lysosomal degradation measured in vitro," J. Bioact. Compat. Polym., 4, 242-251 (1989).
31. A. Trouet, "Isolation of modified liver lysosomes," Methods Enzymol., 31, 323-329 (1974).
32. V. Šubr, J. Kopeček, and R. Duncan, "Degradation of oligopeptide sequences connecting poly[N-(2-hydroxypropyl)methacrylamide] chains by lysosomal cysteine proteinases," J. Bioact. Compat. Polym., 1, 133-146 (1986).
33. J. Pytela, F. Rypáček, M. Metalová, and J. Drobnik, "Synthesis of poly[N-(2-hydroxyethyl)-L-glutamines] with modified side chain," Collect. Czech. Chem. Commun., 54, 1640-1647 (1989).
34. H. C. Chiu, Č. Koňák, P. Kopečková, and J. Kopeček, "Enzymatic degradation of poly(ethylene glycol) modified dextrans," J. Bioact. Compat. Polym., 9, 388-410 (1994).
35. J. B. Fenn, M. Mann, C. K. Meng, S. F. Wong, and C. M. Whitehouse, "Electrosprasy ionization - principle and practice," Mass Spectrosc. Rev., 9, 37-70 (1990).
36. W. D. Fuller, M. S. Verlander, and M. Goodman, "A procedure for the facile synthesis of amino acid N-carboxy anhydrides," Biopolymers, 15, 1869-1871 (1976).
37. H. R. Dickinson and A. Hiltner, "Biodegradation of a poly(α-amino acid) hydrogel. II. In vitro," J. Biomed. Mater. Res., 15, 591-603 (1981).
38. T. Hayashi, Y. Tabata, and A. Nakajima, "Biodegradation of poly(α-amino acid) in vitro," Polym. J., 17, 463-471 (1985).
39. C. J. T. Hoes and J. Feijen, "The application of drugpolymer conjugates in chemotherapy," in Drug Carrier Systems, F. G. Roerdink and F. M. Kroo (eds.), Wiley, New York, 1989, pp. 57-109.
40. A. J. Barrett and M. F. Heath, "Lysosomal enzymes," in Lysosomes: A Laboratory Handbook, J. T. Dingle (ed.), Elsevier, Amsterdam, 1977, pp. 19-145.
41. A. J. Barrett and H. Kirschke, "Cathepsin B, cathepsin H, and cathepsin L," Methods Enzymol., 80, 535-563 (1981).
42. J. Kopeček, P. Rejmanová, J. Strohalm, K. Ulbrich, B. Řhová, V. Chytrý, R. Duncan, and J. B. Lloyd, "Synthetic polymeric drugs," U.S. Pat. 5,037,883 (Aug. 6, 1991).
43. R. Duncan, J. B. Lloyd, and J. Kopeček, "Degradation of side chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal enzymes," Biochem. Biophys. Res. Commun., 94, 284-290 (1980).
44. H.-J. Kärgel, R. Dettmer, G. Etzold, H. Kirschke, P. Bohley, and J. Langner, "Action of cathepsin L on the oxidized B-chain of bovine insulin," FEBS Lett., 114, 257-260 (1980).
45. I. Schlechter and A. Berger, "On the size of the active site in proteases. I. Papain," Biochem. Biophys. Res. Commun., 27, 157-162 (1967).
46. J. Lowbridge and J. S. Fruton, "Studies on the extended active sites of papain," J. Biol. Chem., 249, 6754-6761 (1974).
47. M. Bergman, L. Zervas, and J. S. Fruton, "On proteolytic enzymes. VII. The synthesis of peptides of L-lysine and their behavior with papain," J. Biol. Chem., 111, 225-244 (1935).
48. K. Ulbrich, E. I. Zacharieva, B. Obereigner, and J. Kopeček, "Polymers containing enzymatically degradable bonds. V. Hydrophilic polymers degradable by papain," Biomaterials, 1, 199-204 (1980).
49. J. Pytela, V. Saudek, and F. Rypacek, "Poly(N-hydroxyalkylglutamines). IV. Enzymatic degradation of N-(2-hydroxyethyl)-L-glutamine homopolymers and copolymers," J. Controlled Release, 10, 17-25 (1989).
50. J. Pytela, J. Jakeš, and F. Rypáček, "A study of enzymic degradation of a macromolecular substrate, poly[N-(2-hydroxyethyl)-L-glutamine], by gel permeation chromatography and kinetic modelling," Int. J. Biol. Macromol., 16, 15-20 (1994).
51. H. R. Dickinson, A. Hiltner, D. F. Gibbons, and J. M. Anderson, "Biodegradation of a poly(α-amino acid) hydrogel. I. In vivo," J. Biomed. Mater. Res., 15, 577-589 (1981).
52. Y. Yaacobi, S. Sideman, and N. Lotan, "A mechanistic model for the enzymic degradation for synthetic biopolymers," Life Support Syst., 3, 313-326 (1985).
53. K. Ishiwari, T. Hayashi, and A. Nakajima, "Monomer reactivity ratios in copolymerization of γ-benzyl L-glutamate and L-valine N-carboxyanhydrides," Polym. J., 10, 87-91 (1978).
54. G. Lundblad and B. Johansson, "The characterization of proteolytic enzymes with synthetic poly-α-amino acids," Acta Chem. Scand., 22, 662-674 (1968).